humans |
23 |
animals |
22 |
phylogeny |
17 |
influenza |
16 |
adult |
15 |
disease outbreaks |
14 |
female |
14 |
hemagglutinin |
14 |
influenza virus |
14 |
mutation - genetics |
14 |
antigens, viral - analysis |
13 |
birds - virology |
13 |
d222g |
13 |
pandemic |
13 |
cell line |
12 |
evolution, molecular |
12 |
influenza, human - epidemiology - virology |
12 |
molecular sequence data |
12 |
h1n1 |
11 |
acute hepatitis |
10 |
adaptation |
10 |
bronchiectasis |
10 |
case report |
10 |
chronic obstructive lung disease |
10 |
coronavirus |
10 |
d225g |
10 |
genotype |
10 |
h5n1 |
10 |
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
10 |
influenza a virus, h1n1 subtype - genetics - pathogenicity |
10 |
mice |
10 |
sialic acid |
10 |
airway organoid |
9 |
amino acid substitution |
9 |
hong kong - epidemiology |
9 |
infectivity |
9 |
influenza in birds - epidemiology - virology |
9 |
middle aged |
9 |
oseltamivir |
9 |
poultry - virology |
9 |
proximal differentiation |
9 |
sars |
9 |
young adult |
9 |
a(h3n2) |
8 |
adolescent |
8 |
age factors |
8 |
aged |
8 |
aged, 80 and over |
8 |
antibody |
8 |
base sequence |
8 |
betacoronavirus |
8 |
biology |
8 |
biotechnology technology: comprehensive works medical sciences chemistry |
8 |
child |
8 |
child, preschool |
8 |
clarithromycin |
8 |
cricetinae |
8 |
cross-reactive |
8 |
emc |
8 |
genes, viral - genetics |
8 |
hcov-emc |
8 |
hku1 |
8 |
hospitalized |
8 |
incidence |
8 |
infant |
8 |
influenza a virus, h1n1 subtype - genetics |
8 |
influenza a virus, h1n1 subtype - isolation & purification - pathogenicity |
8 |
influenza, human - epidemiology - pathology - virology |
8 |
male |
8 |
naproxen |
8 |
neutralization |
8 |
novel |
8 |
nucleoprotein |
8 |
oc43 |
8 |
polymerase chain reaction |
8 |
seroprevalence |
8 |
severity of illness index |
8 |
susceptibility |
8 |
antibodies, monoclonal - immunology |
7 |
antibodies, viral - genetics - immunology - metabolism |
7 |
chemicals and cas registry numbers |
7 |
coronavirus - classification - genetics - immunology - metabolism |
7 |
coronavirus hku1 |
7 |
fluorescein-5-isothiocyanate - metabolism |
7 |
fluorescent antibody technique, indirect |
7 |
fluorescent dyes - metabolism |
7 |
furin inhibitor |
7 |
glycoprotein |
7 |
glycosylation |
7 |
hemagglutinins - genetics |
7 |
immunization |
7 |
immunohistochemistry |
7 |
influenza a |
7 |
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification - pathogenicity |
7 |
interferon |
7 |
kidney - cytology |
7 |
life cycle |
7 |
maturation |
7 |
membrane glycoproteins - genetics - immunology - metabolism |
7 |
mice, inbred balb c |
7 |
native conformation |
7 |
nglycosylation |
7 |
physiological processes - genetics |
7 |
recombinant proteins - immunology - metabolism |
7 |
seroepidemiology |
7 |
small-molecule inhibitor |
7 |
spike |
7 |
surface expression |
7 |
transfection |
7 |
viral envelope proteins - genetics - immunology - metabolism |
7 |
virus maturation |
7 |
amantadine-pharmacology |
6 |
amino acid sequence |
6 |
antibodies, viral - blood |
6 |
antiviral |
6 |
avian influenza |
6 |
binding sites |
6 |
biodiversity |
6 |
biodiversity conservation |
6 |
china |
6 |
co-evolution |
6 |
conservation of natural resources |
6 |
dna, viral - classification - genetics |
6 |
drug-resistance,-viral-genetics |
6 |
far east - epidemiology |
6 |
genes, viral |
6 |
genetic variation |
6 |
hemagglutinin glycoproteins, influenza virus - chemistry - genetics |
6 |
influenza a virus, h1n1 subtype - genetics - immunology |
6 |
influenza a virus, h5n1 subtype - classification - genetics |
6 |
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
6 |
influenza a virus, h9n2 subtype - chemistry - classification |
6 |
influenza in birds - diagnosis - genetics - virology |
6 |
influenza in birds - virology |
6 |
influenza, human - diagnosis - genetics - virology |
6 |
influenza, human - diagnosis - virology |
6 |
influenza, human - epidemiology - transmission - virology |
6 |
influenza-a-virus,-h5n1-subtype-drug-effects |
6 |
influenza-a-virus,-h5n1-subtype-genetics |
6 |
middle east |
6 |
molecular diagnostic techniques - methods |
6 |
mutation |
6 |
mycophenolic acid |
6 |
orthomyxoviridae - genetics - isolation & purification - pathogenicity |
6 |
orthomyxoviridae infections - transmission - veterinary - virology |
6 |
owston's civet |
6 |
poultry |
6 |
reassortant viruses - genetics - isolation & purification - pathogenicity |
6 |
ribavirin |
6 |
rimantadine-pharmacology |
6 |
serotyping |
6 |
structural evolution |
6 |
time factors |
6 |
virology - methods |
6 |
viverrid |
6 |
viverridae - anatomy & histology - physiology - virology |
6 |
wild species infections |
6 |
amino acid motifs |
5 |
antiviral agents - pharmacology |
5 |
avian influenza virus |
5 |
bird diseases - epidemiology - virology |
5 |
birds |
5 |
china - epidemiology |
5 |
consensus primers |
5 |
consensus sequence |
5 |
dna primers |
5 |
drug resistance, viral |
5 |
esptein-barr virus |
5 |
h7n9 |
5 |
hemagglutination inhibition tests |
5 |
hemagglutinin glycoproteins, influenza virus - classification - genetics |
5 |
influenza a virus - classification - enzymology - genetics |
5 |
influenza a virus - classification - isolation and purification |
5 |
influenza a virus, h3n2 subtype - genetics - isolation and purification |
5 |
influenza a virus, h5n1 subtype - genetics |
5 |
influenza a virus, h7n9 subtype - genetics - isolation and purification |
5 |
influenza a virus, h9n2 subtype - classification - genetics - isolation & purification |
5 |
molecular epidemiology |
5 |
nasopharyngeal epithelial carcinoma |
5 |
oseltamivir - pharmacology |
5 |
point-of-care systems |
5 |
polymerase chain reaction - methods |
5 |
polymerase genes |
5 |
premalignant nasopharyngeal epithelium |
5 |
prevalence |
5 |
quail - virology |
5 |
reverse transcriptase polymerase chain reaction - methods |
5 |
rna replicase - chemistry - genetics |
5 |
sequence homology, amino acid |
5 |
viral proteins - chemistry - genetics |
5 |
animal migration |
4 |
animals, wild |
4 |
antigenic variation |
4 |
antigens, viral - classification - genetics - immunology |
4 |
asia - epidemiology |
4 |
asia, southeastern - epidemiology |
4 |
astrocytes - virology |
4 |
avian |
4 |
avian influenza a virus |
4 |
bird diseases - epidemiology - transmission - virology |
4 |
birds - physiology - virology |
4 |
blotting, western |
4 |
charadriiformes - physiology - virology |
4 |
clinical |
4 |
cross reactions |
4 |
down-regulation |
4 |
geese - physiology - virology |
4 |
h10n8 |
4 |
h5n1 subtype |
4 |
hemagglutinins, viral - classification - genetics - immunology |
4 |
histopathology |
4 |
hong kong |
4 |
human infection |
4 |
influenza a virus, h1n1 subtype - drug effects |
4 |
influenza a virus, h5n1 subtype - genetics - immunology |
4 |
influenza a virus, h5n1 subtype - genetics - physiology |
4 |
influenza a virus, h5n1 subtype - isolation and purification |
4 |
influenza a virus, h7n9 subtype - immunology - isolation and purification |
4 |
influenza vaccines - genetics - immunology |
4 |
influenza, human - blood - pathology - virology |
4 |
influenza, human - epidemiology - prevention and control - transmission - virology |
4 |
influenza, human - epidemiology - transmission - veterinary - virology |
4 |
influenza, human - metabolism - virology |
4 |
influenza, human - pathology - physiopathology - virology |
4 |
nasopharynx - virology |
4 |
neuraminidase - antagonists & inhibitors - genetics |
4 |
neutralization tests |
4 |
nuclear factor 90 proteins - chemistry - genetics - metabolism |
4 |
nucleoproteins - genetics - metabolism |
4 |
polymorphism, genetic |
4 |
protein conformation |
4 |
tissue tropism |
4 |
virus replication |
4 |
antibodies, monoclonal |
3 |
asia |
3 |
avian influenza a h9n2 |
3 |
biology of infection |
3 |
biomarker |
3 |
bird diseases - virology |
3 |
bone marrow transplantation |
3 |
bone marrow transplantation - adverse effects |
3 |
carcinoma, squamous cell - pathology - virology |
3 |
cell differentiation |
3 |
dna, viral - genetics |
3 |
drug resistance, viral - genetics |
3 |
ebv |
3 |
ebv bart |
3 |
ebv expression |
3 |
epithelial cells |
3 |
epstein-barr virus |
3 |
europe |
3 |
h275y |
3 |
herpesvirus 4, human - genetics - immunology - physiology |
3 |
hpai |
3 |
immunocompromised host |
3 |
in situ hybridization |
3 |
influenza a virus, h1n1 subtype - drug effects - genetics - immunology |
3 |
influenza a virus, h7n7 subtype - classification - genetics |
3 |
influenza a virus, h9n2 subtype - classification - genetics - isolation and purification |
3 |
influenza in birds - genetics |
3 |
influenza, human - complications - diagnosis - pathology - virology |
3 |
mice, inbred balb/c |
3 |
microrna |
3 |
nasopharyngeal carcinoma |
3 |
nasopharyngeal neoplasms - pathology - virology |
3 |
neuraminidase |
3 |
neuraminidase - genetics - immunology - metabolism |
3 |
npc |
3 |
npc differentiation |
3 |
ns1 |
3 |
nuclear localization signal |
3 |
orthomyxoviridae infections - immunology |
3 |
poultry diseases - virology |
3 |
resistance |
3 |
respiratory insufficiency - diagnosis - etiology |
3 |
rna, viral - genetics |
3 |
viral matrix proteins - analysis |
3 |
viral proteins - genetics - immunology - metabolism |
3 |
virus latency |
3 |
adamantane - therapeutic use |
2 |
agrobacterium rhizogenes |
2 |
animal model |
2 |
anti-h5 monoclonal antibody |
2 |
antibodies, viral - immunology |
2 |
antiviral agents - therapeutic use |
2 |
avian metapneumovirus |
2 |
capsid proteins |
2 |
chicken anemia virus |
2 |
chicken anemia virus - classification - genetics |
2 |
chickens |
2 |
chickens - virology |
2 |
circoviridae infections - epidemiology - veterinary - virology |
2 |
cluster analysis |
2 |
commerce |
2 |
disease models, animal |
2 |
dna primers - genetics |
2 |
dot elisa |
2 |
dot-elisa |
2 |
drug sensitivity |
2 |
enzyme-linked immunosorbent assay - methods |
2 |
enzyme-linked immunosorbent assay - methods - statistics & numerical data |
2 |
epstein-barr virus infections - diagnosis - immunology |
2 |
ferret |
2 |
ferrets - virology |
2 |
gene expression |
2 |
gene expression regulation |
2 |
h5n1 avian influenza virus |
2 |
haemagglutination |
2 |
hairy roots |
2 |
hemagglutinin glycoproteins, influenza virus - genetics |
2 |
hepatitis virus |
2 |
herpesvirus 4, human - genetics - immunology |
2 |
human-to-human transmission |
2 |
infection |
2 |
influenza a virus - drug effects - immunology |
2 |
influenza a virus, h5n1 subtype - drug effects - genetics - immunology - metabolism |
2 |
influenza a virus, h5n1 subtype - immunology |
2 |
influenza a virus, h5n1 subtype - immunology - isolation and purification |
2 |
influenza in birds - diagnosis |
2 |
influenza in birds - diagnosis - virology |
2 |
influenza in birds - transmission - virology |
2 |
influenza vaccines - therapeutic use |
2 |
influenza, human - drug therapy - prevention & control |
2 |
influenza, human - epidemiology - immunology - prevention and control |
2 |
influenza, human - virology |
2 |
interferon-alpha - administration and dosage - immunology |
2 |
lamiaceae |
2 |
lithospermic acid b |
2 |
live birds markets |
2 |
mass spectrometric sequencing |
2 |
mers |
2 |
metapneumovirus - classification - genetics |
2 |
mixed infection |
2 |
monoclonal antibody |
2 |
neuraminidase - immunology |
2 |
nigeria |
2 |
orthomyxoviridae infections - epidemiology - immunology - prevention and control |
2 |
orthomyxoviridae infections - transmission - virology |
2 |
paramyxoviridae infections - veterinary |
2 |
pathology |
2 |
peptide mimic |
2 |
peramivir |
2 |
point of care |
2 |
polymorphism of viral antigen |
2 |
poultry diseases - diagnosis - virology |
2 |
poultry diseases - epidemiology - virology |
2 |
proteins - genetics - metabolism |
2 |
rapid test |
2 |
receptor |
2 |
replication and transcription |
2 |
rhesus monkey |
2 |
rosmarinic acid |
2 |
salvia miltiorrhiza |
2 |
selection, genetic |
2 |
sequence analysis, dna - veterinary |
2 |
transcription, genetic |
2 |
turkeys |
2 |
viral envelope proteins - genetics |
2 |
virus replication - genetics |
2 |
a (h1n1) influenza |
1 |
ags cell line |
1 |
animal challenge |
1 |
antibodies, monoclonal - chemistry - immunology - therapeutic use |
1 |
antibodies, monoclonal - genetics - immunology - therapeutic use |
1 |
antibodies, neutralizing - genetics - immunology - therapeutic use |
1 |
antibodies, viral - chemistry - immunology - therapeutic use |
1 |
antibodies, viral - genetics - immunology - therapeutic use |
1 |
antibody profile |
1 |
antigens, viral - biosynthesis - genetics |
1 |
antiviral agents - immunology - therapeutic use |
1 |
avian influenza h9n2 virus |
1 |
avian influenza virus (h9n2) |
1 |
binding sites, antibody |
1 |
body weight |
1 |
border screening |
1 |
broad-spectrum neutralization |
1 |
broadly neutralizing antibodies |
1 |
ccaat-enhancer-binding proteins - genetics - metabolism |
1 |
cell biology |
1 |
cell growth |
1 |
cell line, tumor |
1 |
chick embryo |
1 |
cho cells |
1 |
cholesterol - metabolism |
1 |
cross species transmission |
1 |
cytokeratin |
1 |
cytoplasm - metabolism |
1 |
cytoplasmic actin |
1 |
cytoskeleton - metabolism |
1 |
dna-binding proteins - biosynthesis - genetics |
1 |
ebv-mir-bart8-3p |
1 |
epithelial cells - metabolism - virology |
1 |
epithelial-mesenchymal transition |
1 |
epitope mapping |
1 |
erk1/2 signaling |
1 |
fatty acids - metabolism |
1 |
gc/ms |
1 |
gene expression profiling - methods |
1 |
genome alignment |
1 |
hela cells |
1 |
herpesvirus 4, human - genetics - physiology |
1 |
host adaptation |
1 |
host-pathogen interactions |
1 |
humanized antibody |
1 |
igm |
1 |
immediate-early proteins - biosynthesis - genetics |
1 |
immunoglobulin constant regions - genetics |
1 |
immunoglobulin variable region - genetics |
1 |
influenza a virus |
1 |
influenza a virus - physiology |
1 |
influenza a virus, h5n1 subtype - chemistry |
1 |
influenza a virus, h5n1 subtype - chemistry - genetics - immunology |
1 |
influenza a virus, h9n2 subtype - metabolism |
1 |
influenza b virus |
1 |
influenza, human |
1 |
influenza, human - metabolism |
1 |
influenza, human - transmission |
1 |
keratins - metabolism |
1 |
mass spectrometry - methods |
1 |
mdck cells |
1 |
metabolomics |
1 |
metastasis |
1 |
mir-bart13 |
1 |
multivariate data analysis |
1 |
nanotechnology - methods |
1 |
nf-κb signaling |
1 |
nkiras2 |
1 |
orthomyxoviridae infections - drug therapy - pathology |
1 |
orthomyxoviridae infections - pathology - transmission - veterinary |
1 |
pb2 |
1 |
peptides - chemistry |
1 |
peptides - chemistry - genetics - immunology |
1 |
phylogenetic analysis |
1 |
promoter regions, genetic |
1 |
propagation of virus |
1 |
proteins - chemistry |
1 |
proteomics - methods |
1 |
receptor binding site |
1 |
receptor specificity |
1 |
recombinant fusion proteins - chemistry - genetics - immunology |
1 |
reverse genetics |
1 |
rnp |
1 |
spectrometry, mass, electrospray ionization |
1 |
spectrometry, mass, electrospray ionization - methods |
1 |
stage |
1 |
sulfonation |
1 |
survival analysis |
1 |
tandem mass spectrometry - methods |
1 |
trans-activators - biosynthesis - genetics |
1 |
truncated nucleocapsid protein |
1 |
tumour progression |
1 |
two-dimensional gel electrophoresis |
1 |
vaccine |
1 |
vaccine mismatch |
1 |
viral matrix proteins - chemistry - genetics |
1 |
viral proteins - biosynthesis - genetics |
1 |